Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/1997
03/13/1997WO1997009032A1 Utilization of an extract of a non photosynthetic filamentary bacterium and composition containing such extract
03/13/1997CA2227301A1 Hcv binding protein
03/12/1997EP0761650A1 Thermally stable and storable crystalline modification of N-methyl-N-((1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)-ethyl)-2,2-diphenyl-acetamide and process for its preparation
03/12/1997EP0761207A2 Oral pharmaceutical preparations containing antacids
03/12/1997EP0761204A1 Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them
03/12/1997EP0760855A1 Hepatitis c virus asialoglycoproteins
03/12/1997EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists
03/12/1997EP0760673A1 INHIBITION OF ATTACHMENT OF $i(H. INFLUENZAE) TO HUMAN CELLS
03/12/1997EP0760668A1 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
03/12/1997EP0760664A1 Use of pteridine derivatives as no-synthase inhibitors
03/12/1997EP0760661A1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
03/12/1997EP0693059B1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same
03/12/1997EP0588873B1 Treatment of liver cancer
03/12/1997CN1145075A Antagonist's of endothelin receptors
03/12/1997CN1145074A Carbamoylmethylurea derivative
03/12/1997CN1145071A Heterocyclic compounds and their preparation and use
03/12/1997CN1144801A Beta-Adrenergic agonists
03/12/1997CN1144685A Anti-hepatitis B capsule
03/12/1997CN1144677A Flavanolignan preparation, its processing method and pharmaceutical compositions containing them
03/11/1997US5610176 Tachykinin (NK1) receptor antagonists
03/11/1997US5610157 N-(3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzo-dioxin) carboxamide derivatives
03/11/1997US5610156 Tricyclic benzazepine vasopressin antagonists
03/11/1997US5610146 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use
03/11/1997US5610145 Carbamate stereoisomers
03/11/1997US5610144 Pyrrolidine and thiazolidine derivatives, their preparation and medicaments containing them
03/11/1997US5610054 Enzymatic RNA molecule targeted against Hepatitis C virus
03/11/1997US5609870 Antisecretory, immunology
03/11/1997CA2015505C Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels
03/06/1997WO1997008310A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
03/06/1997WO1997008202A1 Antisecretory factor peptides regulating pathological permeability changes
03/06/1997WO1997008174A1 Interleukin converting enzyme and apoptosis
03/06/1997WO1997008166A1 Piperazino derivatives as neurokinin antagonists
03/06/1997WO1997008144A1 Substituted benzylaminopiperidine compounds
03/06/1997WO1997008143A1 Inhibitors of tumor necrosis factor alpha
03/06/1997WO1997008133A1 Amide compounds and use of the same
03/06/1997WO1997007805A1 Interleukin converting enzyme and apoptosis
03/06/1997WO1997005285A3 Methods and compositions for identifying morphogen analogs
03/06/1997CA2502764A1 Amide compounds
03/06/1997CA2230487A1 Inhibitors of tumor necrosis factor alpha
03/05/1997EP0760365A2 Alkenyl-benzoylguanidines
03/05/1997EP0760241A1 Use of sulfasalazine and its active metabolite for the manufacture of a medicament for the treatment of venous insufficiency and venous ulcers
03/05/1997EP0759979A1 Antisense inhibition of hepatitis c virus
03/05/1997EP0759937A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
03/05/1997EP0759934A1 Neurotensin antagonist peptides
03/05/1997EP0759768A1 Vasoactive intestinal polypeptide
03/05/1997EP0759766A1 EXTRACTS OF $i(STEPHANIA TETRANDRA) FOR INHIBITION OF INTERLEUKIN-6 PRODUCTION
03/05/1997EP0759764A1 Composition for dental use comprising krill enzyme
03/05/1997EP0759751A1 Process for the preparation of acanthoic acid and pharmaceutical composition comprising same
03/05/1997EP0585300B1 Galanin antagonist
03/05/1997CN1144128A Pure traditional Chinese medicinal liquor with antisenile action
03/05/1997CN1144108A Yatongsan powder for curing toothache
03/05/1997CN1034175C Pyrazolopyrimidines compound
03/04/1997US5607978 Prostaglandins for vision defects
03/04/1997US5607960 Indole derivatives as 5-HT1-like agonists for use in migraine
03/04/1997US5607958 Neurotensin receptor binders
03/04/1997US5607932 Bactericides
03/04/1997US5607676 Immunogenic compositions against gastrin peptides
03/04/1997US5607672 Replacement therapy for dental caries
03/04/1997CA2166794C Magnesium omeprazole
03/04/1997CA2077693C Use of ketorolac for treatment of periodontal disease
02/1997
02/27/1997WO1997007334A1 Axial flow valve system for linear compressor
02/27/1997WO1997007198A2 Dna sequences and secreted proteins encoded thereby
02/27/1997WO1997007120A1 Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists
02/27/1997WO1997006822A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
02/27/1997WO1997006816A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions
02/27/1997WO1997006808A1 Combination osmotic and bulk forming laxatives
02/27/1997CA2229658A1 Combination osmotic and bulk forming laxatives
02/27/1997CA2229450A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions
02/27/1997CA2229208A1 Dna sequences and secreted proteins encoded thereby
02/27/1997CA2229140A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
02/26/1997EP0759469A1 Bacteriocin
02/26/1997EP0759067A1 Transforming growth factor alpha h1
02/26/1997EP0759029A1 Modified milk growth factor
02/26/1997EP0759027A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
02/26/1997EP0758892A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
02/26/1997EP0726911A4 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
02/26/1997EP0707581B1 Indoline derivatives as 5ht2c antagonists
02/26/1997CN1143968A Peptides inhibiting release of pepsine
02/26/1997CN1143964A Pyrrolopyridazine derivative
02/26/1997CN1143963A Tetracyclic derivatives, process of preparation and use
02/26/1997CN1143950A Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
02/26/1997CN1143644A N-|(1,4-diazadicyclo |2,2,2¨ oct -2-yl methyl¨ benzoic amide derivatives, its preparing process and medicinal use
02/26/1997CN1143524A Flavouring for curing hepatic disease
02/26/1997CN1143514A Pill for curing gastropathy and preparing process thereof
02/26/1997CN1143507A Specific remedy for curing dysentery and diarrhea of domestic animals and poultry
02/26/1997CN1034123C Calcium channel blocking polypeptides from filistate hibernalis
02/25/1997US5606065 Antagonist of neurokinin receivers
02/25/1997US5606062 Stereoselective reduction
02/25/1997US5605930 Compositions and methods for treating and preventing pathologies including cancer
02/25/1997US5605928 Antiemetic compositions
02/25/1997US5605927 Treatment of skin diseases using ginkgolide PAF antagonists
02/25/1997US5605902 5-HT2 receptor antagonist compositions useful in treating venous conditions
02/25/1997US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites
02/25/1997CA2183937A1 Alkenyl-benzoylguanidine derivatives
02/25/1997CA2049514C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them
02/25/1997CA2030396C 5-[1-(imidazol)methyl]-3,3-disubstituted-2(3h)furanone derivatives
02/25/1997CA1338940C Ó,ó-disubstituted n-cycloalkylalkylbenzylamines, process for their preparation, their use as a medicament and their synthesis intermediates
02/20/1997WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
02/20/1997WO1997006254A1 Human mp52 arg protein
02/20/1997WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof